{arrow_up} Back to top

Risk Minimisation Materials

Search by company, common medicine name, or title of Risk Minimisation Material

0-9 ABCDEFGHIJKLMNOPQRSTUVWXYZ

Yacella

Morningside Healthcare Ltd

{pdf_link}

Yacella - Important Information for Women

The person who prescribes your contraception has given you this sheet to give you a bit more information about the recommendations coming from a recent Europe-wide review of the safety of combined hormonal contraceptives, in particular the risk of blood clots.
{pdf_link}

Yacella Checklist for Prescribers

{healthcare_pro_orange} For Healthcare Professionals
Please use this checklist in conjunction with the Summary of Product Characteristics during combined hormonal contraceptive (CHC) consultations
{pdf_link}

Yacella HCP Letter

{healthcare_pro_orange} For Healthcare Professionals
Recent changes made to Yacella.
{pdf_link}

Yacella Patient Card

Please use this checklist in conjunction with the Summary of Product Characteristics during combined hormonal contraceptive (CHC) consultations

Yasmin

Bayer plc

{pdf_link}

CHCs - Checklist for Prescribers

{healthcare_pro_orange} For Healthcare Professionals
Combined Hormonal Contraceptives - checklist for prescribers
{pdf_link}

CHCs - Q&A on Important Info for Women

Combined hormonal contraceptives: Q&As about the important information for women.
{pdf_link}

CHCs - Risk of Blood Clots with CHCs

Important Information for women about risk of blood clots with combined hormonal contraceptives.

Yaxwer 120 mg solution for injection

Gedeon Richter (UK) Ltd

{pdf_link}

Yaxwer 120 mg solution for injection Patient Reminder Card

Educational Risk Minimisation Materials to help reduce the risk associated with using this medicine.

Yervoy

Bristol Myers Squibb Pharmaceuticals limited

{pdf_link}

Yervoy (ipilimumab) Patient Card

This risk minimisation material is a condition of the marketing authorisation. It contains important safety information that you need to be aware of before, during and after treatment with ipilimumab. Please ensure that you carry this card with you at all times to inform any healthcare professional treating you (e.g., emergency department personnel) that you are receiving treatment with ipilimumab.

Yesafili

Biocon Biologics

{pdf_link}

Yesafili BRVO Patient Guide

BRVO patient support guide

{pdf_link}

Yesafili CNV Patient Guide

mCNV Yesafili patient guide

{pdf_link}

Yesafili CRVO Patient Guide

CRVO Yesafili patient guide

{pdf_link}

Yesafili DMO Patient Guide

DMO Yesafili Patient support guide

{pdf_link}

Yesafili Prescriber Guide

{healthcare_pro_orange} For Healthcare Professionals

Yesafili Prescriber Guide

{pdf_link}

Yesafili wetAMD Patient Guide

wetAMD Yesafili patient guide

Yescarta

Gilead Sciences Ltd

{pdf_link}

YESCARTA_Handling Guide

{healthcare_pro_orange} For Healthcare Professionals
Guide to handling and method of administration: To minimize the potential risk of decrease in viability of the product loss of efficacy due to inappropriate preparation of the Yescarta infusion.
{pdf_link}

YESCARTA_HCP educational guide

{healthcare_pro_orange} For Healthcare Professionals
Healthcare provider (HCP) educational material - To inform HCPs on how to monitor and manage symptoms associated with CRS and serious neurologic adverse reactions, and provide guidance on reporting these serious adverse reactions associated with Yescarta.
{pdf_link}

YESCARTA_Patient Alert Card

Patient Alert Card - To inform patients of the risks of CRS and serious neurologic adverse reactions, associated with Yescarta.

Yuflyma

Celltrion Healthcare UK Limited

{pdf_link}

Yuflyma Adult Patient Reminder Card

patient reminder card (adult)

{pdf_link}

Yuflyma Paediatric Patient Reminder Card

Patient reminder card (Paediatric)

You are trying to reach document intended for healthcare professionals only.

Are you a healthcare professional?

Log in or sign up to avoid further verifications.